Oxygen Biotherapeutics Inc.(OXBT: Quote) reported a first-quarter net loss of $3.6 million, wider than $2.9 million in the prior year quarter. Loss per share for the latest first quarter was $0.22, narrower than $0.33 per share in the same quarter last year.
Net operating loss for the first quarter narrowed to $1.68 million from $2.43 million in the comparable quarter last year.
Total net revenue rose to $272,096 from $24,873 for the comparable quarter in the previous fiscal year.
Product revenue for the quarter decreased to $11,458 compared to $59,477 in the same quarter in 2011 primarily due to the reduction in our internal sales force and termination of existing distribution agreements in the prior year.
Click here to receive FREE breaking news email alerts for Oxygen Biotherapeutics Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com